These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7983501)

  • 21. Two high-frequency-transduction phage isolates from lysogenic strains of Pseudomonas aeruginosa transducing antibiotic resistance.
    Blahová J; Králiková K; Krcméry V; Mikovicová A; Bartoníková N
    Acta Virol; 1998 Jun; 42(3):175-9. PubMed ID: 9842447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
    Sofianou DC; Douboyas JP
    J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
    Knothe H; Krcméry V; Mitsuhashi S
    Zentralbl Bakteriol A; 1980 Mar; 246(3):373-8. PubMed ID: 6775445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipenem resistance in pseudomonas aeruginosa PAO: mapping of the OprD2 gene.
    Quinn JP; Darzins A; Miyashiro D; Ripp S; Miller RV
    Antimicrob Agents Chemother; 1991 Apr; 35(4):753-5. PubMed ID: 1906263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic resistance and molecular typing of Pseudomonas aeruginosa: focus on imipenem.
    de Freitas AL; Barth AL
    Braz J Infect Dis; 2002 Feb; 6(1):1-7. PubMed ID: 11980597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
    Minami S; Akama M; Araki H; Watanabe Y; Narita H; Iyobe S; Mitsuhashi S
    J Antimicrob Chemother; 1996 Mar; 37(3):433-44. PubMed ID: 9182100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibiotic resistance in clinical strains of Pseudomonas aeruginosa isolated from 1979-1984].
    Kozlova EV; Anisimova LA; Boronin AM
    Antibiot Khimioter; 1989 Jan; 34(1):24-8. PubMed ID: 2499281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics of the resistance of Pseudomonas aeruginosa plasmids].
    Anisimova LA; Boronin AM
    Antibiotiki; 1981 Jun; 26(6):450-6. PubMed ID: 6791583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftazidime resistance in Pseudomonas aeruginosa: transduction by a wild-type phage.
    Seginková Z; Krcméry V; Knothe H
    J Infect Dis; 1986 Dec; 154(6):1049-50. PubMed ID: 3097161
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey.
    Bonfiglio G; Carciotto V; Russo G; Stefani S; Schito GC; Debbia E; Nicoletti G
    J Antimicrob Chemother; 1998 Feb; 41(2):307-10. PubMed ID: 9533479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to imipenem in Pseudomonas aeruginosa.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Dec; 36(6):1037-41. PubMed ID: 8821603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host range variability in the transfer of antibiotic resistance determinants from Pseudomonas aeruginosa strains.
    Blahová J; Králiková K; Krcméry V; Schäfer V
    J Chemother; 2000 Jun; 12(3):199-203. PubMed ID: 10877513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutations.
    Gradelski E; Fung-Tomc J; Huczko E; Kessler RE
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():75-80. PubMed ID: 8150769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of imipenem and five other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa.
    Gerçeker AA; Otük G
    Chemotherapy; 1995; 41(5):334-6. PubMed ID: 8521734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of antibiotic resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
    Tzouvelekis LS; Tumah H; Malliara K; Legakis NJ
    J Chemother; 1989 Aug; 1(4):226-30. PubMed ID: 2509643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of F116-mediated transduction of Pseudomonas aeruginosa in a freshwater environment.
    Morrison WD; Miller RV; Sayler GS
    Appl Environ Microbiol; 1978 Nov; 36(5):724-30. PubMed ID: 103503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological study of variations in beta-lactam antibiotic susceptibility of Pseudomonas aeruginosa in two intensive care units.
    Cailleaux V; Mulin B; Capellier G; Julliot MC; Thouverez M; Talon D
    J Hosp Infect; 1997 Nov; 37(3):217-24. PubMed ID: 9421773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains.
    Michel-Briand Y; Nicolas T; Godard C; Plesiat P
    Microbiologica; 1992 Jan; 15(1):65-9. PubMed ID: 1556960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.